| Bioactivity | MEN 10208 is a neurokinin A antagonist prepared by solid phase synthesis. The Fmoc strategy has more advantages than the Boc strategy in its preparation, and can obtain products with higher yield and purity. |
| CAS | 129781-07-3 |
| Sequence | Thr-Asp-Tyr-{d-Trp}-Val-{d-Trp}-{d-Trp}-Arg-NH2 |
| Shortening | TDY-{d-Trp}-V-{d-Trp}-{d-Trp}-R-NH2 |
| Formula | C61H75N15O12 |
| Molar Mass | 1210.34 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Solid-phase synthesis of neurokinin A antagonists. Comparison of the Boc and Fmoc methods |
MEN 10208
CAS: 129781-07-3 F: C61H75N15O12 W: 1210.34
MEN 10208 is a neurokinin A antagonist prepared by solid phase synthesis. The Fmoc strategy has more advantages than the
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.